Eric Liu

Eric Liu is a Partner, Head of North American Private Equity, and Global Co-Head of Healthcare at EQT. EQT is an alternative asset management firm headquartered in Sweden, with over €77 billion in assets under management. He joined in 2014 to establish and build out the firm’s large-cap buyout operations in the U.S. The firm is currently investing EQT IX, a €15.6 billion private equity fund closed in 2021. Eric led the firm’s investments and serves on the Board of Directors of Certara, Parexel, and Waystar, and was previously responsible for Aldevron and Press Ganey. Prior to joining EQT, Eric spent ten years at Warburg Pincus where he was responsible for private equity investments in the healthcare sector, including Bausch & Lomb, Tornier, ev3, and DexCom. Earlier in his career, he worked in private equity at The Blackstone Group and in early-stage venture capital at Draper Fisher Jurvetson.

Eric has a B.A. in Applied Mathematics, phi beta kappa, from Harvard University and an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar.